Calidad de vida de los pacientes sometidos al trasplante de células madre autólogo y alogénico en la hospitalización

  • Celina Angélica Mattos Machado Universidade Federal do Paraná http://orcid.org/0000-0002-7241-7169
  • Sibéli de Fátima Ferraz Simão Proença Complexo Hospital de Clínicas da Universidade Federal do Paraná (CHC-UFPR) – Curitiba, Paraná, Brasil http://orcid.org/0000-0001-9699-0878
  • Angela da Costa Barcellos Marques Complexo Hospital de Clínicas da Universidade Federal do Paraná (CHC-UFPR) – Curitiba, Paraná, Brasil http://orcid.org/0000-0003-1442-0308
  • Maria de Fátima Mantovani Programa de Pós-Graduação em Enfermagem da Universidade Federal do Paraná (UFPR) – Curitiba, Paraná, Brasil. http://orcid.org/0000-0001-7961-8273
  • Paulo Ricardo Bittencourt Guimarães Departamento de Estatítica da Universidade Federal do Paraná (UFPR) – Curitiba, Paraná, Brasil. http://orcid.org/0000-0002-9852-6777
  • Luciana Puchalski Kalinke Programa de Pós-Graduação em Enfermagem da Universidade Federal do Paraná (UFPR) – Curitiba, Paraná, Brasil. http://orcid.org/0000-0003-4868-8193

Resumen

Objetivo: Evaluar la calidad de vida de los pacientes adultos con cáncer hematológico de acuerdo con la modalidad de trasplante de células madre hematopoyéticas durante las etapas de hospitalización.
Método: Estudio cuantitativo, observacional, longitudinal y analítico con 55 participantes adultos diagnosticados con cáncer hematológico sometidos al trasplante de células madre hematopoyéticas desde septiembre de 2013 hasta noviembre de 2015. Se utilizaron tres instrumentos, uno para caracterización sociodemográfica y clínica y dos instrumentos para evaluar la calidad de vida: el Quality Of Life Questionnaire – Core 30 (QLQ-C30), versión 3.0 portugués, desarrollado por la European Organization Research Treatment of Cancer (EORTC) y el cuestionario FunctionalAssessmentCancerTherapy- Bone Marrow Transplantation (FACT-BMT), versión 4.0 portugués, desarrollado por la Functional Assessment of ChronicIllness Therapy (FACIT), ambos validados para Brasil.
Resultado: Los resultados demostraron que el promedio de edad para el trasplante de células madre hematopoyéticas autólogo fue de 45 años, el predominio del diagnóstico mieloma múltiple y para el trasplante de células madre alogénico fue de 31 años y como diagnóstico predominante la leucemia. La evaluación de la calidad de vida con ambos cuestionarios y modalidades demostró descenso significativo de los valores en todos los dominios evaluados, con predominio de peores puntuaciones en el período de pancitopenia, excepto para la función emocional.
Conclusión: La presente investigación concluye que el trasplante de células madre hematopoyéticas altera la calidad de vida durante la hospitalización para ambas modalidades de trasplante. Los enfermeros deben promover intervenciones para mejorar la calidad de vida de los pacientes, abarcando dominios físicos, emocionales, sociales y funcionales.

 

Biografía del autor

Celina Angélica Mattos Machado, Universidade Federal do Paraná
Enfermeira. Mestranda em Enfermagem – Mestrado Profissional. Universidade Federal do Paraná (UFPR) – Curitiba, Paraná, Brasil
Sibéli de Fátima Ferraz Simão Proença, Complexo Hospital de Clínicas da Universidade Federal do Paraná (CHC-UFPR) – Curitiba, Paraná, Brasil
Enfermeira. Mestre em Enfermagem.
Angela da Costa Barcellos Marques, Complexo Hospital de Clínicas da Universidade Federal do Paraná (CHC-UFPR) – Curitiba, Paraná, Brasil
Enfermeira. Mestre em Enfermagem.
Maria de Fátima Mantovani, Programa de Pós-Graduação em Enfermagem da Universidade Federal do Paraná (UFPR) – Curitiba, Paraná, Brasil.
Enfermeira. Doutora em Enfermagem.
Paulo Ricardo Bittencourt Guimarães, Departamento de Estatítica da Universidade Federal do Paraná (UFPR) – Curitiba, Paraná, Brasil.
Estatístico. Doutor em Engenharia Florestal.
Luciana Puchalski Kalinke, Programa de Pós-Graduação em Enfermagem da Universidade Federal do Paraná (UFPR) – Curitiba, Paraná, Brasil.
Enfermeira. Doutora em Ciências da Saúde.

Referencias

Referências

World Health Organization (WHO). Cancer. http://www.who.int/cancer/media/news/cancer-prevention-resolution/en/. 2017. Accessed May 31, 2017.

Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Estimativa 2016: incidência de câncer no Brasil. http://www.inca.gov.br/estimativa/2016/estimativa-2016-v11.pdf. 2016. Accessed March 20, 2017.

Henig I, Zuckerman T. Hematopoietic stem cell transplantation-50 anos de evolução e perspectivas futuras. Rambam Maimonides Medical Journal. 2014; 5(4): 1-15. doi: http://dx.doi.org/10.5041/rmmj.10162.

Niederwieser D, Baldomero H, Szer J, et al. Hematopoietic stem cell transplantation activity wordwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplantation. 2016; 51(6): 778-785. doi: http://dx.doi.org/10.1038/bmt.2016.18.

Timuragaoglu A. The role of the nurses and technicians for stem cell mobilization and collection. Transfusion and apheresis Science. 2015; 53(1): 30-33. doi: http://dx.doi.org/10.1016/j.transci.2015.05.012.

WINGARD JR. Overview of hematopoietic stem cell transplantation. In: WINGARD, J. R. et al. Hematopoietic stem cell transplantation: a handbook for clinicians. Betesda: American Association of Blood Banks, 2015. p. 1-8.

Gyuerkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood. 2014; 124(3): 344-353. doi: https://doi.org/10.1182/blood-2014-02-514778.

HSU JW, HAMADANI M, DEVINE SM. Patient evaluation before transplantation (Adult). In: WINGARD JR. et al. (Ed.). Hematopoietic stem cell transplantation: a handbook for clinicians. Betesda: American Association of Blood Banks, 2015. p. 43-58.

Proença F, Machado CM, Coelho RC, et al. Quality of life of patients with graft-versus-host disease (GvHD) post-hematopoietic stem cell transplantation. Revista da Escola de Enfermagem da USP. 2016; 50(6): 953-960. doi: http://dx.doi.org/10.1590/s0080-623420160000700011.

World Health Organization (WHO). WHOQOL Measuring quality of life. The world health organization quality of life instruments (The WHOQOL 100 and the WHOQOL Bref)”. http://www.who.int/mental_health/media/68.pdf. Accessed May 31, 2017.

El-Jawahri A, Pidala J, Inamoto Y, et al. Impact of age on quality of life, functional status and survival in patients with chronic graft-versus-host disease. Biology of blood and marrow transplantation. 2014; 20(9): 1341-1348. doi: http://dx.doi.org/10.1016/j.bbmt.2014.05.001.

Garcia CM, Mumby PB, Thilge S, et al. Comparison of early quality of life outcomes in autologous and allogeneic transplant patients. Bone Marrow Transplantation. 2012; 47: 1577-1582. doi: http://dx.doi.org/10.1038/bmt.2012.77.

Fayers PM, Aaronson NK, Bjordal K, et al. The EORTC QLQ-C30 scoring manual. Brussels: EORTC. 2001. http://www.eortc.be/qol/fil es/SCManualQLQ-C30.pdf. Accessed December 15, 2016.

Functional Assessement of Chronic Illnes Therapy (FACIT). FACT-BMT Scoring Guidelines (Version 4). Elmhurst: FACIT. 2003. http://www.facit.org/. Accessed July 04, 2016.

Song C, SO HS. Factors influencing changes in quality of life in patients undergoing hematopoietic stem cell transplantation: a longitudinal and multilevel analysis. Journal of Korean Academy of Nursing. 2015; 45 (5): 694-703. doi: http://dx.doi.org/10.4040/jkan.2015.45.5.694.

Poloméni A, Lapusan S, Bompoint C, et al. The impact of allogeneic-hematopoietic stem cell transplantation on patients’and close relatives’quality of life and relationships. European Journal of Oncology Nursing. 2015; 21: 248-256. doi: http://dx.doi.org/10.1016/j.ejon.2015.10.011. Accessed October 10, 2016.

Khera N, Chang YH, Hashmi S, et al. Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biology Blood Marrow Transplant. 2014; 20 (9): 1375-1381. doi: http://dx.doi.org/10.1016/j.bbmt.2014.05.011. Accessed June 24, 2016.

Hamilton JG, Wu LM, Austin JE, et al. Economic survivorship stress is associated with poor health related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psychooncology. 2013; 22 (4): 911-921. doi: http://dx.doi.org/10.1002/pon.3091. Accessed June 17, 2017.

Silva JB, Póvoa VCO, Lima MH de M, et al. Nursing workload in hematopoietic stem cell transplantation: a cohort study. Journal of School of Nursing USP. 2015; 49: 93-100. doi: https://dx.doi.org/10.1590/S0080-623420150000700014. Accessed June 17, 2017.

Seixas MR, Rodríguez LL, Fernández JMP, et al. Calidad de vida relacionada con la salud en pacientes con trasplante de progenitores hematopoyéticos”. Index de Enfermería. 2014; 23(4): 209-213. doi: http://dx.doi.org/10.4321/S1132-12962014000300004. Accessed November 16, 2016.

Sirilla J, Overcash J. Quality of life (QOL), supportive care, and spirituality in hematopoietic stem cell transplant (HSCT) patient. Supportive Care in Cancer. 2013; 21(4): 1137-1144. doi: http://dx.doi.org/10.1007/s00520-012-1637-y. Accessed October 01, 2017.

Cohen MZ, Rozmus CL, Mendoza TR, et al. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. Journal of Pain and Symptom Management. 2012; 44(2): 168-180. doi: http://dx.doi.org/10.1016/j.jpainsymman.2011.08.011. Accessed December 09, 2016.

Associação Brasileira de Transplante de órgãos (ABTO). Registro Brasileiro de Transplantes Estatítica de Transplantes. http://www.abto.org.br/abtov03/default.aspx?mn=457&c=900&s=0&friendly=registro-rasileiro-de-transplantes-estatistica-de-transplantes. 2016. Accessed February 16, 2017.

El-Jawahri AR, Traeger LN, Kuzmuk K, et al. Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation. Cancer. 2015; 121 (5): 951-959. doi: http://dx.doi.org/10.1002/cncr.29149. Accessed December 04, 2016.

Kenzik K, Huang IC, Rizzo JD, et al. Relationships among symptoms, psychosocial factors, and health-related quality of life in hematopoietic stem cell transplant survivors. Supportive Care in Cancer. 2015; 23(3): 797-807. doi: http://dx.doi.org/10.1007/s00520-014-2420-z. Accessed October 15, 2016.

Grant M, Cooke L, Williams AC, et al. Functional status and health-related quality of life among allogeneic transplant patients at hospital discharge: a comparison of sociodemographic, disease, and treatment characteristics. Supportive Care in Cancer. 2012; 20(11): 2697-2704. doi: http://dx.doi.org/10.1007/s00520-012-1389-8. Accessed December 10,2016.

El-Jawahri AR, Vandusen HB, Traeger LN, et al. Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation. Cancer, 2016; 122(5): 806-812. doi: http://dx.doi.org/10.1002/cncr.29818. Accessed April 12, 2017.

Rini C, Emmerling D, Austin J, et al. The effectiveness of caregiver social support is associated with cancer survivors' memories of stem cell transplantation: a linguistic analysis of survivor narratives. Palliative & Supportive Care. 2015; 13(6): 1735-1744. doi: http://dx.doi.org/10.1017/S1478951515000681. Accessed April 13, 2017.

Beeken RJ, Eiser C, Dalley C. Health-related quality of life in haematopoietic stem cell transplant survivors: a qualitative study on the role of psychosocial variables and response shifts. Quality of life research. 2011; 20(2): 153-169. doi: http://dx.doi.org/10.1007/s11136-010-9737-y. Accessed April 12, 2017.

Ovayolu O, Ovayolu N, Kaplan E, et al. Symptoms and quality of life before and after stem cell transplantation in Cancer. 2013; 29(3): 803-808. doi: http://dx.doi.org/10.12669/pjms.293.3290. Accessed April 14, 2017.

Grulke N, Albani C, Bailer H. Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30. Bone Marrow Transplantation. 2012; 47: 473-482. doi: http://dx.doi.org/10.1038/bmt.2011. Accessed June 13, 2017.

Pereira DTS, Andrade LL, Agra GA, et al. Therapeutic conducts used in pain management in oncology. Cuidado é fundamental: Revista Online de Pesquisa. 2015; 7(1): 1883-1890. doi: http://dx.doi.org/10.9789/2175-5361.2015.v7i1.1890. Accessed June 12, 2017.

Publicado
09-10-2018
Cómo citar
1.
Machado C, Proença S, Marques A, Mantovani M, Guimarães P, Kalinke L. Calidad de vida de los pacientes sometidos al trasplante de células madre autólogo y alogénico en la hospitalización. eglobal [Internet]. 9oct.2018 [citado 19oct.2018];17(4):401-45. Available from: http://revistas.um.es/eglobal/article/view/eglobal.17.4.304281
Sección
Originales